Latest Nephrology Stories
Pivotal Phase 3 Data Highlight Safety, Efficacy of AMG 416 THOUSAND OAKS, Calif., May 29, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced pooled data from two pivotal
DUBLIN, May 25, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/mqk96k/research_and)
MIQS, developers of award-winning clinical dialysis software, have released a new dialysis billing package, offering dialysis clinics a new option in billing solutions. Boulder,
For-profit Dialysis Chain Agreement Terminated NEW YORK, May 21, 2015 /PRNewswire-USNewswire/ -- Today, the NYC Health and Hospitals Corporation (HHC) cancelled a contract with Big
Kidney-friendly recipes help dialysis patients enjoy the holiday while maintaining a healthy diet DENVER, May 21, 2015 /PRNewswire/ -- DaVita
Zero Discharge Technologies reissues results of critical independent review. Chicopee, MA (PRWEB) May 15, 2015 Zero Discharge Technologies has re-posted
DENVER, May 13, 2015 /PRNewswire/ -- DaVita
LONDON, May 7, 2015 /PRNewswire/ -- Phosphate Therapeutics Limited ("Phosphate Therapeutics"), a development-stage specialty pharmaceuticals company, today announces positive
Leading dialysis manufacturer forms group of esteemed experts to advance leadership and the standard of care LAWRENCE, Mass., May 4, 2015 /PRNewswire/ -- NxStage Medical, Inc.
DENVER, May 4, 2015 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc.
Hypertension is a peer-reviewed scientific journal established in 1979 and published monthly by the American Heart Association (AHA). As of May 2012, the editor-in-chief is John E. Hall (University of Mississippi). Publishing formats include original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letter to the editor, and novel findings of unusual interest. This journal focuses on...
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.